Purple Biotech (PPBT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PPBT Purple Biotech

Watchlist

0.400
+0.030+8.08%

Close Jul 26 16:00 ET

0.412
+0.012+3.03%

Post 20:02 ET

13.56MMarket Cap-506P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Purple Biotech Gets Extension to Regain Nasdaq Compliance
MT NewswiresJul 25 14:44 ET
Purple Biotech Granted Nasdaq Compliance Extension
TipRanksJul 25 07:57 ET
Express News | Purple Biotech Receives Extension From Listing Qualifications Department Of Nasdaq To Regain Compliance With Minimum $1.00 Bid Price Requirement
BenzingaJul 25 07:39 ET
Purple Biotech Receives Extension to Regain Compliance With the Nasdaq's Minimum Bid Price Rule
Globe NewswireJul 25 07:35 ET
Express News | Purple Biotech Receives Extension to Regain Compliance With the Nasdaq’s Minimum Bid Price Rule
ReutersJul 25 07:35 ET
Purple Biotech Eyes Key 2024 Milestones
TipRanksJul 19 09:18 ET

Comments

Trytosaveabit

Jul 25 06:38

Update

$Purple Biotech(PPBT.US)$ Reuters·
Purple Biotech Receives Extension to Regain Compliance With the Nasdaq’s Minimum Bid Price Rule

Amp

Jun 27 18:58

$Purple Biotech(PPBT.US)$ Hopefully someone throws some money at this company or buy them out.

The World’s ATM

Jun 27 07:46

$Purple Biotech(PPBT.US)$ one hour show only

Trytosaveabit

Jun 3 04:03

Watching

$Purple Biotech(PPBT.US)$ Reported Saturday, Purple Biotech Revealed Results From A Phase 2 Study At ASCO 2024, Showing CM24 Improved Overall Survival And Other Efficacy Endpoints In Pancreatic Cancer
26% reduction in risk of death (HR=0.74) and 28% risk reduction in progression or death (HR=0.72) in previously-treated patients administered with CM24+nivolumab+Nal/IRI/5FU/LV vs. standard-of-care(SoC) based on preliminary interim data
Prolongation of 2.1 months in median overall survival ...